Cervical Spinal Cord Injury
Cervical spinal cord injury refers to damage to the spinal cord in the neck region, which can lead to varying degrees of loss of function, sensation, and mobility in the arms and legs.
Acute Spinal Cord Injury: NG004 Treatment
We are testing a new antibody treatment for patients with acute spinal cord injuries to see if it is safe and well-tolerated. This study will help us understand how the treatment works in the body.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 70 years old?
- Are you pregnant or breastfeeding?
- Do you have any major medical conditions like severe lung, liver, or heart disease?
- Are you currently taking blood thinners like Warfarin, Eliquis, or Xarelto?
- Have you had any major spinal cord injury or trauma in the past?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ng004
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Klinikum Bayreuth GmbH
Klinik fuer Querschnittgelaehmte
Bayreuth, Germany
BG Klinikum Bergmannstrost Halle gGmbH
Zentrum fuer Rueckenmarkverletzte
Halle (Saale), Germany
BG Unfallklinik Murnau gGmbH
Zentrum fuer Rueckenmarkverletzte
Murnau am Staffelsee, Germany
Sponsor: NovaGo Therapeutics AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.